Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
206650.KQ
HOLDEuBiologics Co., Ltd. · Healthcare · South Korea · $214M · Avg Vol: $2M/d
59
StockRankQ
68
V
59
M
21
P/E (TTM)
7.8x
ROE
—
D/E
0.1x
Dividend %
—
COMPANY DESCRIPTION
EuBiologics Co., Ltd., a biopharmaceutical company, focuses on developing vaccines against global pandemic and bacterial vaccines primarily in South Korea.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | — | 36.1M | 45.2M | 62.5M | 97.2M | 39.1% |
| EPS | — | -0.02 | -0.25 | 0.34 | 0.73 | 115.1% |
| Shares | — | 36.4M | 36.5M | 36.5M | 36.6M | +0.5% |
| Debt | 2.6M | 10.2M | 9.6M | 8.4M | 2.6M | -0.0% |
| Equity | — | 81.1M | 72.5M | 86.0M | 114.2M | 12.1% |
| Op CF | — | 4.2M | 17.2M | 28.1M | 32.0M | 96.8% |
| Inv CF | — | -1.4M | -18.3M | -17.6M | -25.9M | — |
| Fin CF | — | 0.4M | 0.4M | -2.5M | -5.4M | — |
Loading...
PRICE (1Y)-30.5%
SMA 50SMA 200
Close
$5.36
RSI (14)
42.7
52W High
$11.53
From 52W High
0.5%
SCORE BREAKDOWN
Quality
68
ROIC
27.6%95.8
ROE
—N/A
GP/Assets
39.6%78.5
Op. Margin
35.2%95.3
FCF/Assets
13.4%92.1
Piotroski
782.3
Int. Cover
50.0x88.5
D/E Ratio
0.14x60.0
Current Ratio
—N/A
Value
59
P/E (TTM)
7.8x93.2
EV/EBITDA
—N/A
P/FCF
10.1x82.3
P/B
1.8x62.6
P/S
3.3x53.1
Div Yield
—N/A
Momentum
21
52W High %
46%24.0
RS 6M
-137%4.9
SMA 50/200
0.89x34.4
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$214M
P/E (Forward)
—
Gross Margin
100.0%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 206650.KQ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 206650.KQ | EuBiologics Co., Ltd.(you) | $214M | 59 | HOLD |
| 200670.KQ | Humedix Co., Ltd. | $191M | 55 | HOLD |
| 476060.KQ | Onconic Therapeutics | $454M | 57 | HOLD |
| 293480.KS | Hana Pharm Co., Ltd. | $103M | 61 | HOLD |
| 271980.KS | Jeil Pharmaceutical Co.,Ltd | $98M | 55 | HOLD |
| 243070.KQ | Huons Co., Ltd. | $210M | 80 | STRONG BUY |
| 106190.KQ | High Tech Pharm Co., Ltd. | $100M | 66 | BUY |
| 003000.KS | Bukwang Pharmaceutical Co., Ltd. | $272M | 39 | HOLD |
| 176750.KQ | DuChemBIO Co.,Ltd. | $110M | 46 | HOLD |
| 003090.KS | Daewoong Co., Ltd. | $464M | 69 | BUY |
Peer medians: ROE 0.1% · P/E 16.8x · Gross margin 43.8%